FY/Q4 2017 Investor Conference Call

Wednesday, February 28, 2018
Start at approx. 2:00 p.m. CET (1:00 p.m. UTC)


Investor News February 28, 2018

Fiscal 2017:

Bayer: business at prior-year level - on track with strategy

Group sales increased by 1.5 percent (Fx & portfolio adj.) to 35.015 billion euros / Another record year for Pharmaceuticals / Weak business development at Consumer Health / Crop Science business down against prior year due to situation in Brazil - measures taking effect / EBITDA before special items level year on year at 9.288 billion euros / Net income raised by 61.9 percent to 7.336 billion euros / Core earnings per share increased by 1.0 percent to 6.74 euros / Covestro deconsolidated - additional cash inflows of 4.7 billion euros / Monsanto acquisition expected to close in second quarter of 2018 / Group outlook for 2018: increase in sales (Fx & portfolio adj.), EBITDA before special items and core earnings per share at prior-year level due to currency effects


baumann

Werner Baumann
CEO of Bayer AG

Audio recording of the investor conference call

?

Audio file

You can also play the audio recording on your mobile device.

Dietsch_Live_Events_7fe744

Johannes Dietsch
CFO of Bayer AG

Presentation charts

Annual Report 2017

Q4 2017 Analyst and Investor Briefing

Transcript

FY/Q4 2017 All in One Package for Investors and Analysts

?